Functional modulation on macrophage by low dose naltrexone (LDN)
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 39, 397-402
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low-Dose Naltrexone to Prevent Intolerable Morphine Adverse Events: A Forgotten Remedy for a Neglected, Global Clinical NeedPain Medicine, 2015
- Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous WoundsAdvances in Wound Care, 2014
- Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)International Immunopharmacology, 2013
- Naltrindole Inhibits Human Multiple Myeloma Cell Proliferation In Vitro and in a Murine Xenograft Model In VivoThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responsesCancer Immunology, Immunotherapy, 2012
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled TrialDigestive Diseases and Sciences, 2011
- Kappa-opioid receptor-mediated modulation of innate immune response by dynorphin in teleost Channa punctatusPeptides, 2010
- β-Endorphin regulates diverse functions of splenic phagocytes through different opioid receptors in freshwater fish Channa punctatus (Bloch): An in vitro studyDevelopmental & Comparative Immunology, 2008
- Studies of EN-1639A (Naltrexone): A New Narcotic AntagonistAmerican Journal of Psychiatry, 1974
- Naltrexone, an Antagonist for the Treatment of Heroin DependenceArchives of General Psychiatry, 1973